81
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease

, , , , &
Pages 155-162 | Published online: 05 Feb 2014

References

  • PriceLCLoweDHoskerHSAnsteyKPearsonMGRobertsCMBritish Thoracic Society and the Royal College of Physicians Clinical Effectiveness Evaluation Unit (CEEu)UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbationThorax2006611083784216449268
  • VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • WakabayashiKGonzalezMADelhayeCImpact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarctionAm J Cardiol2010106330530920643237
  • DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
  • BrekkePHOmlandTSmithPSøysethVUnderdiagnosis of myocardial infarction in COPD – Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbationRespir Med200810291243124718595681
  • RenderMLWeinsteinASBlausteinASLeft ventricular dysfunction in deteriorating patients with chronic obstructive pulmonary diseaseChest199510711621687813269
  • NiHNaumanDJHershbergerREManaged care and outcomes of hospitalization among elderly patients with congestive heart failureArch Intern Med199815811123112369625402
  • HavranekEPMasoudiFAWestfallKAWolfePOrdinDLKrumholzHMSpectrum of heart failure in older patients: results from the National Heart Failure projectAm Heart J2002143341241711868045
  • BraunsteinJBAndersonGFGerstenblithGNoncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failureJ Am Coll Cardiol20034271226123314522486
  • GustafssonFTorp-PedersenCBurchardtHDIAMOND Study GroupFemale sex is associated with a better long-term survival in patients hospitalized with congestive heart failureEur Heart J200425212913514720529
  • HolguinFFolchEReddSCManninoDMComorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001Chest200512842005201116236848
  • RuttenFHCramerMJGrobbeeDEUnrecognized heart failure in elderly patients with stable chronic obstructive pulmonary diseaseEur Heart J200526181887189415860516
  • CurkendallSMDeLuiseCJonesJKCardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patientsAnn Epidemiol2006161637016039877
  • Le JemtelTHPadelettiMJelicSDiagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failureJ Am Coll Cardiol200749217118017222727
  • IversenKKKjaergaardJAkkanDECHOS-Lung Function Study GroupChronic obstructive pulmonary disease in patients admitted with heart failureJ Intern Med2008264436136918537871
  • PadelettiMJelicSLeJemtelTHCoexistent chronic obstructive pulmonary disease and heart failure in the elderlyInt J Cardiol2008125220921518221802
  • BarrRGBluemkeDAAhmedFSPercent emphysema, airflow obstruction, and impaired left ventricular fillingN Engl J Med2010362321722720089972
  • CowieMRStruthersADWoodDAValue of natriuretic peptides in assessment of patients with possible new heart failure in primary careLancet19973509088134913539365448
  • MaiselASKrishnaswamyPNowakRMBreathing Not Properly Multinational Study InvestigatorsRapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failureN Engl J Med2002347316116712124404
  • RuttenFHMoonsKGCramerMJRecognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic studyBMJ20053317529137916321994
  • MorrisonLKHarrisonAKrishnaswamyPKazanegraRCloptonPMaiselAUtility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspneaJ Am Coll Cardiol200239220220911788208
  • GreenSMMartinez-RumayorAGregorySAClinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspneaArch Intern Med2008168774174818413557
  • JanuzziJLJrCamargoCAAnwaruddinSThe N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) studyAm J Cardiol200595894895415820160
  • PesolaGRThe use of B-type natriuretic peptide (BNP) to distinguish heart failure from lung disease in patients presenting with dyspnea to the emergency departmentAcad Emerg Med200310327527712615595
  • DicksteinKCohen-SolalAFilippatosGESC Committee for Practice Guidelines (CPG)ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Eur Heart J200829192388244218799522
  • BozkanatETozkoparanEBaysanODenizOCiftciFYokusogluMThe significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary diseaseJ Int Med Res200533553754416222887
  • AbrougFOuanes-BesbesLNciriNAssociation of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkersAm J Respir Crit Care Med2006174999099616840745
  • InoueYKawayamaTIwanagaTAizawaHHigh plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonaleIntern Med200948750351219336951
  • AbusaidGHBarbagelataATueroEMahmoodASharmaGDiastolic dysfunction and COPD exacerbationPostgrad Med20091214768119641273
  • IwanagaYNishiIFuruichiSB-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failureJ Am Coll Cardiol200647474274816487838
  • NishimuraKYasuiMNishimuraTOgaTClinical pathway for acute exacerbations of chronic obstructive pulmonary disease: method development and five years of experienceInt J Chron Obstruct Pulmon Dis2011636537221760723
  • LiebermanDLiebermanDGelferYPneumonic vs nonpneumonic acute exacerbations of COPDChest200212241264127012377851
  • MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J200526231933816055882
  • Japan Society of Chest Diseases: The predicted values of pulmonary function testing and arterial blood gas in JapaneseJpn J Thorac Dis2001395appendix Japanese
  • StolzDBreidthardtTChrist-CrainMUse of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPDChest200813351088109418339792
  • AurigemmaGPGaaschWHClinical practice. Diastolic heart failureN Engl J Med2004351111097110515356307
  • VasanRSLevyDDefining diastolic heart failure: a call for standardized diagnostic criteriaCirculation2000101172118212110790356
  • ChangCLRobinsonSCMillsGDBiochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPDThorax201166976476821474497
  • GaleCPWhiteJEHunterAPredicting mortality and hospital admission in patients with COPD: significance of NT pro-BNP, clinical and echocardiographic assessmentJ Cardiovasc Med (Hagerstown)201112961361821792022
  • HøisethADOmlandTHagveTABrekkePHSøysethVNT-proBNP independently predicts long term mortality after acute exacerbation of COPD – a prospective cohort studyRespir Res2012139723107284
  • TzaniPAielloMEliaDDynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patientsRespir Res20111215022074289
  • ParkerCMVoducNAaronSDWebbKAO’DonnellDEPhysiological changes during symptom recovery from moderate exacerbations of COPDEur Respir J200526342042816135722
  • FujimotoKYasuoMUrushibataKHanaokaMKoizumiTKuboKAirway inflammation during stable and acutely exacerbated chronic obstructive pulmonary diseaseEur Respir J200525464064615802337